Characterising and preventing the gut microbiota’s inactivation of trifluridine, a colorectal cancer drug
The colon targeting efficacies of mesalazine medications and their impacts on the gut microbiome
Expediting 3D printed medication development using vacuum compression moulding
Investigating the bidirectional interactions between senotherapeutic agents and human gut microbiota
Effects of senotherapeutics on gut microbiome dysbiosis and intestinal inflammation in Crohn’s disease: A pilot study
3D printing personalised therapies for paediatric patients affected by adrenal insufficiency
Entering new domains for 3D printing of drug products
Sex-specific formulations of doxazosin mesylate via direct powder extrusion 3D printing
Advances in Colon-Targeted Drug Delivery Technologies
BRG wins ‘Science is Art’ lab coat competition at UCL SoP Christmas Lunch 2024
